NEJM Evidence Issues Research Articles in July 2023 Edition
July 05, 2023
July 05, 2023
WALTHAM, Massachusetts, July 5 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its July 2023 edition:
Original Articles:
* Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery
* Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve
* Plasma Epstein-Barr . . .
Original Articles:
* Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery
* Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve
* Plasma Epstein-Barr . . .